About Clinical Research

Quick Facts

Clinical research studies must be performed before a new medication or treatment can potentially be approved for use and available to the public.
There are common traits that people must have to participate in a study, called eligibility criteria. Common criteria include age, gender, medical history, and other medical conditions.

Right now, there are more than 400,000 studies in progress around the world.1
Many conditions affect diverse groups of people, so it is important to have diverse groups of people participating in research. Different people may respond differently to treatments.

[1] https://clinicaltrials.gov/ct2/resources/trends

Diversity & Inclusion in Clinical Research

Janssen is committed to improving diversity and inclusion in research studies while valuing each participant’s contribution. By including all diverse populations in research studies, Janssen can help determine if investigational medications will be safe and effective for as many people as possible, which helps to create a better future for patients.

It’s important for all communities to have a voice in clinical research. By being more inclusive, we can:

Help provide access to promising investigational medications to underserved communities
Aid in supporting the development of effective treatments for all patients
Help build trust for clinical research in underserved communities
Potentially increase awareness of how basic research learnings can turn into real-life knowledge that can directly impact human health

See If You May Qualify